Aspocomp July-September operating result rises to EUR 1.3 million; July-September net sales climb 20% to EUR 10.6 million
Bitget2026/10/28 07:04- Aspocomp's July-September operating result rose to EUR 1.3 million, while net sales climbed 20% to EUR 10.6 million.
- Orders received more than doubled to EUR 15.3 million; the September-end order book increased 85% to EUR 30.6 million.
- Defense became the largest customer segment for the first time, accounting for 40% of July-September net sales.
- Five production lines were commissioned during July-September, including two addressing bottlenecks that had caused production losses.
- The 2026 outlook remained unchanged, with net sales expected to grow and operating result to improve compared with 2025.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Trump Media & Technology Group plunges over 24%, hitting a new low since listing.
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.
CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.
AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Crypto prices
More
